Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Schteingart

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Opinion on Emerging Drugs|November 27, 2009
Drugs in the medical treatment of Cushing's syndromeDavid E Schteingart
The New England Journal of Medicine|June 8, 2007
Adjuvant mitotane therapy of adrenal cancer - use and controversyDavid E Schteingart
Current Opinion in Endocrinology, Diabetes, and Obesity|April 14, 2012
The clinical spectrum of adrenocortical hyperplasiaDavid E Schteingart
Expert Opinion on Emerging Drugs|April 27, 2012
Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotideDavid E Schteingart
The Journal of Laboratory and Clinical Medicine|January 26, 2005
The 50th anniversary of the identification of primary aldosteronism: a retrospective of the work of Jerome W. ConnDavid E Schteingart
Endocrinology and Metabolism Clinics of North America|June 12, 2002
Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretionLiselle Douyon, David E Schteingart
Neurosurgery Clinics of North America|April 15, 2003
Management options for persistent functional tumorsWilliam F Chandler, Ariel L Barkan, David E Schteingart
Biological Psychiatry|February 1, 2003
Improvement in learning associated with increase in hippocampal formation volumeMonica N Starkman, Bruno Giordani, Stephen S Gebarski, et al.
Anticancer Research|December 29, 2010
Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapyDavid E Schteingart, Ricardo Benitez, Carol Bradford, et al.
Head & Neck|November 26, 2008
Location of ectopic adrenocortical hormone-secreting tumors causing Cushing's syndrome in the paranasal sinusesIsrael Hodish, Thomas J Giordano, Monica N Starkman, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Emerging Drugs|November 27, 2009
Drugs in the medical treatment of Cushing's syndromeDavid E Schteingart
The New England Journal of Medicine|June 8, 2007
Adjuvant mitotane therapy of adrenal cancer - use and controversyDavid E Schteingart
Current Opinion in Endocrinology, Diabetes, and Obesity|April 14, 2012
The clinical spectrum of adrenocortical hyperplasiaDavid E Schteingart
Expert Opinion on Emerging Drugs|April 27, 2012
Drugs in the medical treatment of Cushing's syndrome--an update on mifepristone and pasireotideDavid E Schteingart
The Journal of Laboratory and Clinical Medicine|January 26, 2005
The 50th anniversary of the identification of primary aldosteronism: a retrospective of the work of Jerome W. ConnDavid E Schteingart
Endocrinology and Metabolism Clinics of North America|June 12, 2002
Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretionLiselle Douyon, David E Schteingart
Neurosurgery Clinics of North America|April 15, 2003
Management options for persistent functional tumorsWilliam F Chandler, Ariel L Barkan, David E Schteingart
Biological Psychiatry|February 1, 2003
Improvement in learning associated with increase in hippocampal formation volumeMonica N Starkman, Bruno Giordani, Stephen S Gebarski, et al.
Anticancer Research|December 29, 2010
Expression of anti-apoptosis genes determines the response of adrenal cancer to apoptosis-inducing chemotherapyDavid E Schteingart, Ricardo Benitez, Carol Bradford, et al.
Head & Neck|November 26, 2008
Location of ectopic adrenocortical hormone-secreting tumors causing Cushing's syndrome in the paranasal sinusesIsrael Hodish, Thomas J Giordano, Monica N Starkman, et al.
Pageof 3